↓ Skip to main content

Cochrane Database of Systematic Reviews

Antidepressant drugs for narcolepsy

Overview of attention for article published in Cochrane database of systematic reviews, January 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

blogs
1 blog
twitter
1 tweeter
wikipedia
1 Wikipedia page

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
81 Mendeley
Title
Antidepressant drugs for narcolepsy
Published in
Cochrane database of systematic reviews, January 2008
DOI 10.1002/14651858.cd003724.pub3
Pubmed ID
Authors

Luca Vignatelli, Roberto D'Alessandro, Livia Candelise

Abstract

Narcolepsy is a disorder of the central nervous system, the main symptoms of which are excessive daytime sleepiness (EDS) and cataplexy (an abrupt and reversible decrease in or loss of muscle tone, affecting the limbs or trunk or both, elicited by emotional stimuli). Narcolepsy has an adverse impact on people's quality of life. Together with stimulant drugs (used to control EDS), antidepressants are usually recommended to counteract cataplexy. In addition, some antidepressants are also reported to improve EDS.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 1%
United States 1 1%
Unknown 79 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 15%
Student > Doctoral Student 10 12%
Student > Bachelor 10 12%
Researcher 9 11%
Other 9 11%
Other 21 26%
Unknown 10 12%
Readers by discipline Count As %
Medicine and Dentistry 38 47%
Psychology 11 14%
Social Sciences 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Neuroscience 3 4%
Other 10 12%
Unknown 12 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2019.
All research outputs
#1,574,973
of 14,647,097 outputs
Outputs from Cochrane database of systematic reviews
#4,209
of 11,035 outputs
Outputs of similar age
#21,832
of 184,024 outputs
Outputs of similar age from Cochrane database of systematic reviews
#43
of 109 outputs
Altmetric has tracked 14,647,097 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,035 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.4. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 184,024 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.